NEPHROS, INC. Share-based Payment Arrangement, Expense
NEPHROS, INC. (NEPH) reported Share-based Payment Arrangement, Expense of $300.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-03-12
- NEPHROS, INC. share-based payment arrangement, expense for the quarter ending 2023-03-31 was -$27.00K.
- NEPHROS, INC. share-based payment arrangement, expense for the quarter ending 2021-12-31 was $897.00K.
- NEPHROS, INC. share-based payment arrangement, expense for the quarter ending 2018-12-31 was $152.00K, a 14.29% increase year-over-year.
- NEPHROS, INC. share-based payment arrangement, expense for the quarter ending 2018-09-30 was $120.00K, a 9.09% increase year-over-year.
- NEPHROS, INC. share-based payment arrangement, expense for fiscal 2025 was $300.00K, a 200.00% increase from fiscal 2024.
- NEPHROS, INC. share-based payment arrangement, expense for fiscal 2024 was $100.00K, a 87.50% decline from fiscal 2023.
- NEPHROS, INC. share-based payment arrangement, expense for fiscal 2023 was $800.00K, a 11.11% decline from fiscal 2022.
- NEPHROS, INC. share-based payment arrangement, expense for fiscal 2022 was $900.00K, a 0.00% change from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $300.00K 10-K · filed 2026-03-12 | ||||
| 2024-12-31 | $100.00K 10-K · filed 2026-03-12 | ||||
| 2023-12-31 | $800.00K 10-K · filed 2025-03-24 | $1.00M 10-K · filed 2024-03-15 | |||
| 2023-03-31 | -$27.00K 10-Q · filed 2023-05-10 | ||||
| 2022-12-31 | $900.00K 10-K · filed 2024-03-15 | ||||
| 2021-12-31 | $897.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $900.00K 10-K · filed 2023-03-23 | |||
| 2021-09-30 | $3.00K 10-Q · filed 2021-11-04 | ||||
| 2020-12-31 | $700.00K 10-K · filed 2022-03-03 | ||||
| 2019-12-31 | $900.00K 10-K · filed 2021-03-01 | $867.00K 10-K · filed 2020-02-27 | |||
| 2018-12-31 | $152.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $272.00K derived: sum of 2 quarters · filed 2020-02-27 | $396.00K derived: sum of 3 quarters · filed 2020-02-27 | $525.00K 10-K · filed 2020-02-27 | |
| 2018-09-30 | $120.00K 10-Q · filed 2018-11-08 | $244.00K derived: sum of 2 quarters · filed 2018-11-08 | $373.00K 10-Q · filed 2018-11-08 | $507.00K derived: sum of 4 quarters · filed 2019-03-12 | |
| 2018-06-30 | $124.00K 10-Q · filed 2018-08-08 | $253.00K 10-Q · filed 2018-08-08 | $387.00K derived: sum of 3 quarters · filed 2019-03-12 | $497.00K derived: sum of 4 quarters · filed 2019-03-12 | |
| 2018-03-31 | $130.00K 10-Q · filed 2018-05-09 | $263.00K derived: sum of 2 quarters · filed 2019-03-12 | $373.00K derived: sum of 3 quarters · filed 2019-03-12 | $484.00K derived: sum of 4 quarters · filed 2019-03-12 | |
| 2017-12-31 | $133.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $243.00K derived: sum of 2 quarters · filed 2019-03-12 | $354.00K derived: sum of 3 quarters · filed 2019-03-12 | $456.00K 10-K · filed 2019-03-12 | |
| 2017-09-30 | $110.00K 10-Q · filed 2018-11-08 | $221.00K derived: sum of 2 quarters · filed 2018-11-08 | $323.00K 10-Q · filed 2018-11-08 | $412.00K derived: sum of 4 quarters · filed 2018-11-08 | |
| 2017-06-30 | $111.00K 10-Q · filed 2018-08-08 | $213.00K 10-Q · filed 2018-08-08 | $302.00K derived: sum of 3 quarters · filed 2018-08-08 | $406.00K derived: sum of 4 quarters · filed 2018-08-08 | |
| 2017-03-31 | $102.00K 10-Q · filed 2018-05-09 | $191.00K derived: sum of 2 quarters · filed 2018-05-09 | $295.00K derived: sum of 3 quarters · filed 2018-05-09 | $387.00K derived: sum of 4 quarters · filed 2018-05-09 | |
| 2016-12-31 | $89.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $193.00K derived: sum of 2 quarters · filed 2018-02-26 | $285.00K derived: sum of 3 quarters · filed 2018-02-26 | $388.00K 10-K · filed 2018-02-26 | |
| 2016-09-30 | $104.00K 10-Q · filed 2017-11-09 | $196.00K derived: sum of 2 quarters · filed 2017-11-09 | $299.00K 10-Q · filed 2017-11-09 | $421.00K derived: sum of 4 quarters · filed 2017-11-09 | |
| 2016-06-30 | $92.00K 10-Q · filed 2017-08-08 | $194.00K 10-Q · filed 2017-08-08 | $317.00K derived: sum of 3 quarters · filed 2017-08-08 | $412.00K derived: sum of 4 quarters · filed 2017-08-08 | |
| 2016-03-31 | $102.00K 10-Q · filed 2017-05-09 | $225.00K derived: sum of 2 quarters · filed 2017-05-09 | $320.00K derived: sum of 3 quarters · filed 2017-05-09 | $410.00K derived: sum of 4 quarters · filed 2017-05-09 | |
| 2015-12-31 | $123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-20 | $218.00K derived: sum of 2 quarters · filed 2017-03-20 | $308.00K derived: sum of 3 quarters · filed 2017-03-20 | $328.00K 10-K · filed 2017-03-20 | |
| 2015-09-30 | $95.00K 10-Q · filed 2016-11-10 | $185.00K derived: sum of 2 quarters · filed 2016-11-10 | $205.00K 10-Q · filed 2016-11-10 | $308.00K derived: sum of 4 quarters · filed 2016-11-10 | |
| 2015-06-30 | $90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $110.00K 10-Q · filed 2015-08-10 | $213.00K derived: sum of 3 quarters · filed 2016-03-30 | $307.00K derived: sum of 4 quarters · filed 2016-03-30 | |
| 2015-03-31 | $20.00K 10-Q · filed 2015-05-15 | $123.00K derived: sum of 2 quarters · filed 2016-03-30 | $217.00K derived: sum of 3 quarters · filed 2016-03-30 | $323.00K derived: sum of 4 quarters · filed 2016-03-30 | |
| 2014-12-31 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $197.00K derived: sum of 2 quarters · filed 2016-03-30 | $303.00K derived: sum of 3 quarters · filed 2016-03-30 | $421.00K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $94.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $200.00K derived: sum of 2 quarters · filed 2015-11-10 | $318.00K 10-Q · filed 2015-11-10 | $436.00K derived: sum of 4 quarters · filed 2015-11-10 | |
| 2014-06-30 | $106.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $224.00K 10-Q · filed 2015-08-10 | $342.00K derived: sum of 3 quarters · filed 2015-08-10 | $436.00K derived: sum of 4 quarters · filed 2015-08-10 | |
| 2014-03-31 | $118.00K 10-Q · filed 2015-05-15 | $236.00K derived: sum of 2 quarters · filed 2015-05-15 | $330.00K derived: sum of 3 quarters · filed 2015-05-15 | $425.00K derived: sum of 4 quarters · filed 2015-05-15 | |
| 2013-12-31 | $118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | $212.00K derived: sum of 2 quarters · filed 2015-04-15 | $307.00K derived: sum of 3 quarters · filed 2015-04-15 | $418.00K 10-K · filed 2015-04-15 | |
| 2013-09-30 | $94.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $189.00K derived: sum of 2 quarters · filed 2014-11-13 | $300.00K 10-Q · filed 2014-11-13 | $408.00K derived: sum of 4 quarters · filed 2014-11-13 | |
| 2013-06-30 | $95.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $206.00K 10-Q · filed 2014-08-14 | $314.00K derived: sum of 3 quarters · filed 2014-08-14 | $481.00K derived: sum of 4 quarters · filed 2014-08-14 | |
| 2013-03-31 | $111.00K 10-Q · filed 2014-05-14 | $219.00K derived: sum of 2 quarters · filed 2014-05-14 | $386.00K derived: sum of 3 quarters · filed 2014-05-14 | ||
| 2012-12-31 | $108.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $275.00K derived: sum of 2 quarters · filed 2014-03-28 | $443.00K 10-K · filed 2014-03-28 | ||
| 2012-09-30 | $167.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $335.00K 10-Q · filed 2013-11-14 | |||
| 2012-06-30 | $168.00K 10-Q · filed 2013-08-13 | ||||
| 2011-12-31 | $256.00K 10-K · filed 2013-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |